6.
Peeler C, Mirkovic D, Titt U, Blanchard P, Gunther J, Mahajan A
. Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma. Radiother Oncol. 2016; 121(3):395-401.
PMC: 5450501.
DOI: 10.1016/j.radonc.2016.11.001.
View
7.
Mazal A, Prezado Y, Ares C, De Marzi L, Patriarca A, Miralbell R
. FLASH and minibeams in radiation therapy: the effect of microstructures on time and space and their potential application to protontherapy. Br J Radiol. 2020; 93(1107):20190807.
PMC: 7066940.
DOI: 10.1259/bjr.20190807.
View
8.
Vozenin M, Hendry J, Limoli C
. Biological Benefits of Ultra-high Dose Rate FLASH Radiotherapy: Sleeping Beauty Awoken. Clin Oncol (R Coll Radiol). 2019; 31(7):407-415.
PMC: 6850216.
DOI: 10.1016/j.clon.2019.04.001.
View
9.
No H, Wu Y, Dworkin M, Manjappa R, Skinner L, Ashraf M
. Clinical Linear Accelerator-Based Electron FLASH: Pathway for Practical Translation to FLASH Clinical Trials. Int J Radiat Oncol Biol Phys. 2023; 117(2):482-492.
DOI: 10.1016/j.ijrobp.2023.04.011.
View
10.
Patel D, Bronk L, Guan F, Peeler C, Brons S, Dokic I
. Optimization of Monte Carlo particle transport parameters and validation of a novel high throughput experimental setup to measure the biological effects of particle beams. Med Phys. 2017; 44(11):6061-6073.
DOI: 10.1002/mp.12568.
View
11.
Favaudon V, Caplier L, Monceau V, Pouzoulet F, Sayarath M, Fouillade C
. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 2014; 6(245):245ra93.
DOI: 10.1126/scitranslmed.3008973.
View
12.
Schuler E, Acharya M, Montay-Gruel P, Loo Jr B, Vozenin M, Maxim P
. Ultra-high dose rate electron beams and the FLASH effect: From preclinical evidence to a new radiotherapy paradigm. Med Phys. 2022; 49(3):2082-2095.
PMC: 9032195.
DOI: 10.1002/mp.15442.
View
13.
Wilson J, Hammond E, Higgins G, Petersson K
. Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?. Front Oncol. 2020; 9:1563.
PMC: 6979639.
DOI: 10.3389/fonc.2019.01563.
View
14.
Mascia A, Daugherty E, Zhang Y, Lee E, Xiao Z, Sertorio M
. Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial. JAMA Oncol. 2022; 9(1):62-69.
PMC: 9589460.
DOI: 10.1001/jamaoncol.2022.5843.
View
15.
Yang M, Wang X, Guan F, Titt U, Iga K, Jiang D
. Adaptation and dosimetric commissioning of a synchrotron-based proton beamline for FLASH experiments. Phys Med Biol. 2022; 67(16).
PMC: 9422888.
DOI: 10.1088/1361-6560/ac8269.
View
16.
Yovino S, Kleinberg L, Grossman S, Narayanan M, Ford E
. The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest. 2013; 31(2):140-4.
PMC: 3991115.
DOI: 10.3109/07357907.2012.762780.
View
17.
Daugherty E, Mascia A, Zhang Y, Lee E, Xiao Z, Sertorio M
. FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases (FAST-01): Protocol for the First Prospective Feasibility Study. JMIR Res Protoc. 2022; 12:e41812.
PMC: 9893728.
DOI: 10.2196/41812.
View
18.
Jaccard M, Duran M, Petersson K, Germond J, Liger P, Vozenin M
. High dose-per-pulse electron beam dosimetry: Commissioning of the Oriatron eRT6 prototype linear accelerator for preclinical use. Med Phys. 2017; 45(2):863-874.
DOI: 10.1002/mp.12713.
View
19.
Shi J, Xu K, Keyvanloo A, Udayakumar T, Ahmad A, Yang F
. A Multimodality Image Guided Precision Radiation Research Platform: Integrating X-ray, Bioluminescence, and Fluorescence Tomography With Radiation Therapy. Int J Radiat Oncol Biol Phys. 2020; 108(4):1063-1072.
DOI: 10.1016/j.ijrobp.2020.06.023.
View
20.
Schuler E, Trovati S, King G, Lartey F, Rafat M, Villegas M
. Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator. Int J Radiat Oncol Biol Phys. 2016; 97(1):195-203.
DOI: 10.1016/j.ijrobp.2016.09.018.
View